Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study.
Primary Purpose
Acute Spinal Cord Injury
Status
Completed
Phase
Phase 1
Locations
India
Study Type
Interventional
Intervention
autologous bone marrow cell
Sponsored by
About this trial
This is an interventional treatment trial for Acute Spinal Cord Injury
Eligibility Criteria
Inclusion Criteria:
- Acute spinal cord injury between 10 days and 14 days post injury.
- The subject must have a traumatic spinal cord injury between the spinal segmental levels T1 and T12 (Neurological Level).
- Must have a complete injury (ASIA-A).
Exclusion Criteria:
- Subject whose medical condition requires mechanical ventilation.
- Subjects with neurological level of injury above T1 and below T12.
- Subjects more than 14 days and less than 10 days post-injury.
- Lower motor neuron injury.
- Subjects with pathological fracture.
- Spinal Injuries in subjects with Ankylosing Spondylitis.
- Subjects with extremes of age: less than 18 years or more than 50 years.
- Subjects with pre-existing severe medical disease which would affect the outcome like severe diabetes, rheumatoid arthritis.
- Subjects with Psychological disorders.
- Female subjects with pregnancy.
Sites / Locations
- Indian Spinal Injury Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
Experimental
Arm Label
Control
Transplantation via intrathecal route
Transplantation via intralesional route
Arm Description
control subjects with acute complete spinal cord injury who would not receive any bone marrow transplantation.
Subjects with acute complete spinal cord injury who receive autologous bone marrow cell transplantation via lumber puncture
Subjects with acute complete spinal cord injury who receive autologous bone marrow cell transplantation via durotomy and injection at the lesional site .
Outcomes
Primary Outcome Measures
Examine for improvement in the ASIA classification.
Blinded assessors will examine for improvement in the ASIA classification of at least one grade by 12 months or change from baseline of 10 points or more in total motor score, with consideration of their distribution along the neuraxis, from the ASIA Impairment Scale (AIS) manual motor test by 12 months.
Secondary Outcome Measures
Any voluntary movement by additional muscle groups not included in International Standards for Neurological Classification of Spinal Cord Injury
Improvement by at least 1 point on the WISCI scale
Decrease in spasticity by one grade or more as assessed by Modified Ashworth Spasticity Scale
Improvement in ASIA sensory examination
Improvements in SCIM score
Psychological evaluation
Improvements in EMG
Improvements in SSEP
Improvements in MEP
Significant change in any of the variables included in urodynamic assessment
Improvements in any of the variables included in ISCIS
Full Information
NCT ID
NCT02260713
First Posted
September 16, 2014
Last Updated
March 9, 2018
Sponsor
Indian Spinal Injuries Centre
Collaborators
Indian Council of Medical Research
1. Study Identification
Unique Protocol Identification Number
NCT02260713
Brief Title
Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study.
Official Title
Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
February 2011 (Actual)
Primary Completion Date
November 2017 (Actual)
Study Completion Date
November 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Indian Spinal Injuries Centre
Collaborators
Indian Council of Medical Research
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Pilot study on 7 subjects in each group (total 21 subjects) to establish the safety and feasibility of autologous bone marrow cell transplantation in case of acute complete spinal cord injury by each of the following techniques and a corresponding number of controlled subjects:
Directly into the injured site with a syringe after exposing the spinal cord.
By Intrathecal injection.
Detailed Description
Intervention : Autologous bone marrow cell: Transplantation of the autologous bone marrow cell transplantation through one of the below mentioned techniques: 1. Directly into the injured spinal cord site with a syringe after exposing the spinal cord. 2. By Intrathecal injection. Number of cells Injected: 200 million cells in 1.8 ml of autologous plasma. In case of Direct delivery, the cells were delivered in one sitting at six sites ( 2 above the lesion, 2 at the lesion and 2 below the lesion) as 0.3 ml aliquots each. In case of Intrathecal injection, the cells were delivered as a single injection of 1.8ml via lumbar puncture. Frequency of Injection: Single Total duration of Therapy: The procedure of Bone marrow harvesting, enrichment and transplantation was completed in a single setting of approximately 2-3 hours. The transplantation procedure in case of Direct delivery took 2 mins per injection site that is approximately 12 mins and in case of lumbar puncture the transplantation procedure took approximately 2 mins.
Comparator Agent:Control: control subjects with acute complete spinal cord injury who would not receive any bone marrow transplantation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Spinal Cord Injury
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Description
control subjects with acute complete spinal cord injury who would not receive any bone marrow transplantation.
Arm Title
Transplantation via intrathecal route
Arm Type
Experimental
Arm Description
Subjects with acute complete spinal cord injury who receive autologous bone marrow cell transplantation via lumber puncture
Arm Title
Transplantation via intralesional route
Arm Type
Experimental
Arm Description
Subjects with acute complete spinal cord injury who receive autologous bone marrow cell transplantation via durotomy and injection at the lesional site .
Intervention Type
Biological
Intervention Name(s)
autologous bone marrow cell
Intervention Description
Transplantation of 200 million cells in 1.8 ml of autologous plasma in a single sitting. In case of intralesional route, the cells were delivered in one sitting at six sites ( 2 above the lesion, 2 at the lesion and 2 below the lesion) as 0.3 ml aliquots each. In case of Intrathecal route, the cells were delivered as a single injection of 1.8ml via lumbar puncture.
Primary Outcome Measure Information:
Title
Examine for improvement in the ASIA classification.
Description
Blinded assessors will examine for improvement in the ASIA classification of at least one grade by 12 months or change from baseline of 10 points or more in total motor score, with consideration of their distribution along the neuraxis, from the ASIA Impairment Scale (AIS) manual motor test by 12 months.
Time Frame
up to 5 years
Secondary Outcome Measure Information:
Title
Any voluntary movement by additional muscle groups not included in International Standards for Neurological Classification of Spinal Cord Injury
Time Frame
up to 5 years
Title
Improvement by at least 1 point on the WISCI scale
Time Frame
up to 5 years
Title
Decrease in spasticity by one grade or more as assessed by Modified Ashworth Spasticity Scale
Time Frame
up to 5 years
Title
Improvement in ASIA sensory examination
Time Frame
up to 5 years
Title
Improvements in SCIM score
Time Frame
up to 5 years
Title
Psychological evaluation
Time Frame
up to 5 years
Title
Improvements in EMG
Time Frame
up to 5 years
Title
Improvements in SSEP
Time Frame
up to 5 years
Title
Improvements in MEP
Time Frame
up to 5 years
Title
Significant change in any of the variables included in urodynamic assessment
Time Frame
up to 5 years
Title
Improvements in any of the variables included in ISCIS
Time Frame
up to 5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Acute spinal cord injury between 10 days and 14 days post injury.
The subject must have a traumatic spinal cord injury between the spinal segmental levels T1 and T12 (Neurological Level).
Must have a complete injury (ASIA-A).
Exclusion Criteria:
Subject whose medical condition requires mechanical ventilation.
Subjects with neurological level of injury above T1 and below T12.
Subjects more than 14 days and less than 10 days post-injury.
Lower motor neuron injury.
Subjects with pathological fracture.
Spinal Injuries in subjects with Ankylosing Spondylitis.
Subjects with extremes of age: less than 18 years or more than 50 years.
Subjects with pre-existing severe medical disease which would affect the outcome like severe diabetes, rheumatoid arthritis.
Subjects with Psychological disorders.
Female subjects with pregnancy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr Harvinder S Chhabra, MS
Organizational Affiliation
Indian Spinal Injuries Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indian Spinal Injury Center
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110070
Country
India
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
26282492
Citation
Chhabra HS, Sarda K, Arora M, Sharawat R, Singh V, Nanda A, Sangodimath GM, Tandon V. Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study. Spinal Cord. 2016 Jan;54(1):57-64. doi: 10.1038/sc.2015.134. Epub 2015 Aug 18.
Results Reference
result
Learn more about this trial
Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study.
We'll reach out to this number within 24 hrs